Navigation Links
Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting

believes that some of the newer products, product candidates or new indications for existing products, may face competition when and as they are approved and marketed. Amgen products may compete against products that have lower prices, established reimbursement, superior performance, are easier to administer, or that are otherwise competitive with our products. In addition, while Amgen routinely obtains patents for Amgen's products and technology, the protection offered by Amgen's patents and patent applications may be challenged, invalidated or circumvented by Amgen's competitors and there can be no guarantee of Amgen's ability to obtain or maintain patent protection for Amgen's products or product candidates. Amgen cannot guarantee that it will be able to produce commercially successful products or maintain the commercial success of Amgen's existing products. Amgen's stock price may be affected by actual or perceived market opportunity, competitive position, and success or failure of Amgen's products or product candidates. Further, the discovery of significant problems with a product similar to one of Amgen's products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on Amgen's business and results of operations.

The scientific information discussed in this news release related to our product candidates is preliminary and investigative. Such product candidates are not approved by the U.S. Food and Drug Administration (FDA), and no conclusions can or should be drawn regarding the safety or effectiveness of the product candidates. Only the FDA can determine whether the product candidates are safe and effective for the use(s) being investigated. Further, the scientific information discussed in this news release relating to new indications for our products is preliminary and investigative and is not part of the labeling approved by the FDA for the products. The products are not approved for the
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Aranesp ``145 Study Shows No Difference in Survival in Patients with Small-Cell Lung Cancer
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:4/17/2015)... -- CVS Health Corporation (NYSE: CVS ) will ... 2015, at 8:30 a.m. (EDT) with analysts and investors ... An audio webcast of the conference call will be ... CVS Health website for all interested parties. To access ... be archived and available on the web site for ...
(Date:4/17/2015)... and DETROIT , April 17, 2015 ... live in poverty, the infant mortality rate is two and ... per 1,000 live births. Nearly 6 of 10 infants that ... adequate prenatal care.  These are sobering statistics that Covenant Community ... people of Metro Detroit, is poised to change thanks to ...
(Date:4/17/2015)... Today, the Pharmaceutical Research and Manufacturers ... biopharmaceutical companies as "We Work For Health Champions" ... community service. Established in 2009, the ... by the biopharmaceutical industry to honor employees who ... have also shown an outstanding commitment to their ...
Breaking Medicine Technology:Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 2Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 3Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 4PhRMA Applauds 2015 We Work For Health Champion Award Winners 2PhRMA Applauds 2015 We Work For Health Champion Award Winners 3
... provider of bioanalytical accelerator mass spectrometry (AMS) services in ... measurement service at $99 per sample. GLP-compliant service is ... includes sample graphitization and AMS measurement services. Accium will ... at competitive rates. "This new pricing ...
... 19 The National Association of State Controlled ... grant from Purdue Pharma L.P. today at the ... The grant is part of Purdue Pharma,s ongoing ... of appropriately-designed state prescription drug monitoring programs, which ...
Cached Medicine Technology:Accium BioSciences Announces $99 Sample Pricing for Its Accelerator Mass Spectrometry (AMS) Measurement Service 2NASCSA Receives $200,000 Grant From Purdue Pharma L.P. to Support State Prescription Drug Monitoring Programs 2
(Date:4/18/2015)... 18, 2015 Carinsurancesavings.biz has released a ... are cheaper during Spring. , Spring can ... plan. Drivers should make sure they compare the newest ... Clients can learn more about Spring car insurance offers ... Auto insurance quotes are becoming more and more popular. ...
(Date:4/18/2015)... 18, 2015 Review of Ophthalmology magazine ... ‘Strategies for Success’ program for cataract surgeons attending the ... San Diego, where eye surgeon Jeffrey L. Martin, MD ... event. Dr. Martin is the Managing Partner of North ... chose Dr. Martin to lead this year’s discussion on ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 Patients who ... of developing mesothelioma later in life, but the disease ... mesothelioma that is unrelated to radiation. Surviving Mesothelioma has ... its website. Click here to read it now. ... compared the cases of 45 patients who had both ...
(Date:4/18/2015)... 18, 2015 On April 14th, 2015, Symantec ... , which they say, “exposes a tactical shift by cyberattackers.” ... variants were introduced in 2014 - almost a million a ... threats to be identified and patched by prominent manufacturers – ... that doing business in a digital world can be fraught ...
(Date:4/18/2015)... 18, 2015 French physician and gastronome ... choices when he uttered, “Tell me what you eat, ... food to cope with stress or sadness has often ... indicates otherwise. Data collected from their Emotional ... to emotional eating, but for different reasons. , Collecting ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Plans Are Cheaper During Spring! 2Health News:Dr. Jeffrey Martin Invited to Share Latest Breakthroughs in Cataract Care During Roundtable Discussion at National 2015 ASCRS Meeting In San Diego 2Health News:New Study Examines Relationship Between Radiation for Hematologic Cancers and Development of Mesothelioma, According to Surviving Mesothelioma 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 3Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 4Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 5Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 2Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 3Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 4Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 5Health News:It’s Not Just A Girl Thing: Queendom Study Reveals That Men Struggle With Emotional Eating Too 6
... Reflecting the expanding,scope of chronic disease care and ... on health care systems and practices, DMAA: The,Care ... have renamed,the peer-reviewed journal of DMAA Population Health ... (formerly Disease Management) begins with,the August 2008 issue ...
... biologics during Psoriasis Awareness Month , , MONDAY, Aug. 25 (HealthDay ... of thick, inflamed skin covered with silvery scales form here ... knees, other parts of the legs, scalp, lower back, face, ... feel sore, and the more of the patches there are, ...
... Researchers may be closer to understanding why anti-cancer drugs ... immune cells, haven,t fared well in clinical trials. The ... ability of these drugs to shrink well-established tumors, will ... Journal of Experimental Medicine . , The immune system,s ...
... of developing cancers of the respiratory tract, according to a ... the first prospective investigation of incense and cancer risk, appears ... a peer-reviewed journal of the American Cancer Society. , Incense ... of Asia. Researchers have shown that burning incensewhich is made ...
... Newsweek previews,the Democratic National Convention. Editor Jon Meacham opens ... and often complex relationships,Obama has had with his father, ... into who he is today. Meacham writes that,while growing ... comfortable in his own,skin, reconciling his black and white ...
... engaged medical consumers is a long standing goal of ... a new consumer guide containing hundreds of facts, action ... in their quest for medical care that is safe ... immersed in our health care system as her late ...
Cached Medicine News:Health News:Disease Management Journal Changes Name and Expands Focus to Population Health Management 2Health News:After Fits and Starts, New Hope for Psoriasis Patients 2Health News:After Fits and Starts, New Hope for Psoriasis Patients 3Health News:Burning incense increases risk of respiratory tract cancers 2Health News:NEWSWEEK: Media Lead Sheet/September 1, 2008 Issue (on newsstands Monday, August 25, 2008). 2Health News:NEWSWEEK: Media Lead Sheet/September 1, 2008 Issue (on newsstands Monday, August 25, 2008). 3Health News:NEWSWEEK: Media Lead Sheet/September 1, 2008 Issue (on newsstands Monday, August 25, 2008). 4Health News:NEWSWEEK: Media Lead Sheet/September 1, 2008 Issue (on newsstands Monday, August 25, 2008). 5Health News:Mother of Child Cancer Victim Rallies Patient and Families to Guard Against Hidden Dangers in Today's Hospital Care 2Health News:Mother of Child Cancer Victim Rallies Patient and Families to Guard Against Hidden Dangers in Today's Hospital Care 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: